PR Newswire consumer technology company news·· 7 days agoAI score33
Wellysis’s AI ECG analysis software, S-Patch CardioAI, receives FDA 510(k) clearance
AI overview
Wellysis’s AI ECG analysis software, S-Patch CardioAI, received FDA 510(k) clearance on September 25, 2026, and was classified as a Class II medical device.
Source illustrations
Image source:PR Newswire consumer technology company news · Select an image to enlarge it.
Source:PR Newswire consumer technology company news · prnewswire.com